PREDICTING THE EFFICIENCY OF PHYSICAL THERAPY OF PNEUMONIA PATIENTS WITH CORONAVIRUS DISEASE DURING REHABILITATION STAGES
DOI:
https://doi.org/10.32782/2522-1795.2024.18.2.3Keywords:
coronavirus disease, rehabilitation, prediction, transforming growth factor β, cardiorespiratory enduranceAbstract
The aim is to develop a predictive model for the effectiveness of physical therapy in improving cardiorespiratory endurance in patients with pneumonia during the rehabilitation stages of COVID-19. Material. During the hospitalization phase, 42 patients with coronavirus disease were enrolled in the study. Patients were randomly allocated into the main (n=21) and control (n=21) groups. The physical therapy program for the main group included stretching exercises for upper limb, chest, and trunk muscles. Additionally, all patients in the main group were assigned exercises focused on normalizing breathing, irrespective of the presence of productive cough and/or moist rales. All patients underwent questionnaires, anthropometry, assessment of weakness and cough severity, upper limb muscle strength, balance, and cardiorespiratory endurance. In the long-term rehabilitation stage, the study included 30 patients. Patients performed the physical rehabilitation program individually or in groups of 3–4 individuals, five days a week for six weeks after discharge. All patients underwent questionnaires, anthropometry, assessment of quality of life, cardiorespiratory endurance, lung involvement degree evaluation, and quantitative analysis of the transforming growth factor β1 (TGF-β1). The results. The most significant factors predicting improvement in the 6-minute walk test at the end of the stationary rehabilitation phase were the scores of the “Up and Go” test (regression coefficient B=-4.1) and the strength of the non-dominant upper limb muscles (B=2.3). The developed model predicts outcomes within 14% of existing values, indicating satisfactory performance (determination coefficient 42%). In the long term, at 6 weeks, 6 months, and 12 months, the levels of C-reactive protein (B=-0.34, B=-0.4, and B=-0.3, respectively), transforming growth factor β (B=-0.76, B=-0.73, and B=-0.72, respectively) in serum, and the level of physical functioning according to the SF-36 questionnaire (B=1.46, B=0.72, and B=0.85, respectively) were significant. The developed models predict outcomes within 6%, 19%, 21%, respectively (determination coefficient 76%, 62%, 60%, respectively), indicating satisfactory and effective performance. Conclusions. On the post-acute rehabilitation stage, the most significant indicators for predicting the restoration of cardiorespiratory endurance were the strength of the non-dominant upper limb muscles and the balance test scores, while during the long-term rehabilitation period, the levels of TGF-β and CRP in the serum of patients during the illness were key indicators.
References
Фізична реабілітація, спортивна медицина. / Абрамов В.В. та ін. Дніпропетровськ : Журфонд, 2014. 455 с.
Математичні методи оброблення та моделювання результатів експериментальних досліджень. / Антомонов М.Ю. та ін. Київ : «Олімпійська література», 2021. 216 с.
Корота Ю.В., Неханевич О.Б. Ефективність стаціонарної фізичної реабілітації хворих на пневмонію при коронавірусній хворобі. Rehabilitation and Recreation. 2023. № 14, С. 56–62. DOI:10.32782/2522-1795.2023.14.6.
Перцева Т.О., Авраменко І. В. Особливості лабораторних показників перебігу тяжкої негоспітальної пневмонії у пацієнтів. Медичні перспективи, Т. 22, № 2. С. 24–31. DOI: 10.26641/2307-0404.2017.2.109714.
Про затвердження Протоколу надання реабілітаційної допомоги пацієнтам з короновірусною хворобою (COVID -19) та реконвалесцентам : Наказ Міністерства охорони здоров’я України від 20.04.2021 року № 771 / Міністерство охорони здоров’я України. URL: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-20042021--771-pro-zatverdzhennja-protokolunadannja-reabilitacijnoi-dopomogi-pacientamz-koronavirusnoju-hvoroboju--covid-1-9-ta-rekonvalescentam (дата звернення: 16.02.2024).
Adamo S. et al. A Machine Learning Approach to Predict the Rehabilitation Outcome in Convalescent COVID-19 Patients. Journal of personalized medicine. 2022. Vol. 12. No. 3. P. 328. DOI: 10.3390/jpm12030328.
Al Chikhanie Y. et al. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respiratory physiology & neurobiology. 2021. No. 287. P. 103639. DOI: 10.1016/j.resp.2021.103639.
Amdal C.D. et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2021. Vol. 30. No. 12. P. 3367–3381. DOI: 10.1007/s11136-021-02908-z.
Frischbutter S. et al. Serum TGF-β as a predictive biomarker for severe disease and fatality of COVID-19. European journal of immunology. 2023. Vol. 53. No. 10. P. e2350433. DOI: 10.1002/eji.202350433.
Ghossein-Doha C. et al. Prevalence, pathophysiology, prediction and health-related quality of life of long COVID: study protocol of the longitudinal multiple cohort CORona Follow Up (CORFU) study. BMJ open. 2022. Vol. 12. No. 11, P. e065142. DOI: 10.1136/bmjopen-2022-065142.
Hockele L.F. et al. Pulmonary and Functional Rehabilitation Improves Functional Capacity, Pulmonary Function and Respiratory Muscle Strength in Post COVID-19 Patients: Pilot Clinical Trial. International journal of environmental research and public health. 2022. Vol. 19. No. 22. DOI: 10.3390/ijerph192214899.
Kamal M. et al. Assessment and characterisation of post-COVID-19 manifestations. International journal of clinical practice. 2021. Vol. 75. No. 3. DOI: 10.1111/ijcp.13746.
Singh S.J. et al. An official systematic review of the European Respiratory Society/ American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. European respiratory journal. 2014. Vol. 44. No. 6. P. 1447–1478. DOI: 10.1183/09031936.00150414.
Susak F. et al. TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD-A Prospective Case-Control Study. Microorganisms. 2023. Vol. 11. No. 6. P. 1571. DOI: 10.3390/microorganisms11061571.
Tallarico R.T. et al. Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients. Intensive care medicine. 2022. Vol. 48. No. 9. P. 1245–1247. DOI: 10.1007/s00134-022-06797-9.
Tseng B.Y., Gajewski B.J., Kluding P.M. Reliability, responsiveness, and validity of the visual analog fatigue scale to measure exertion fatigue in people with chronic stroke: a preliminary study. Stroke research and treatment. 2010. Vol. 2010. P. 1–7. DOI: 10.4061/2010/412964.
Wiersinga W.J. et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020. Vol. 324. No. 8. P. 782–793. DOI: 10.1001/jama.2020.12839.
Zhang Q. et al. 6MWT Performance and its Correlations with VO₂ and Handgrip Strength in Home-Dwelling Mid-Aged and Older Chinese. International journal of environmental research and public health. 2017. Vol. 14. No. 5. P. 473. DOI: 10.3390/ijerph14050473.
Zhao Y. et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Molecular psychiatry. 2023. Vol. 28. No. 4. P. 1793–1801. DOI: 10.1038/s41380-023-01951-1.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.